跳至主要内容
临床试验/NCT00773110
NCT00773110终止2 期

Scavenging Free Haemoglobin Attenuates the Systemic Inflammatory Response Following Surgery

Imperial College London1 个研究点 分布在 1 个国家目标入组 232 人开始时间: 2008年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
232
试验地点
1
主要终点
Time from surgery to intensive care unit discharge

研究概览

简要总结

The purpose of this study is to determine whether albumin administration during cardiac surgery is effective in attenuating the development of inflammation following surgery.

详细描述

The host response to infection and other forms of tissue injury has been termed the systemic inflammatory response syndrome (SIRS). SIRS is seen in association with a wide variety of non-infective insults, including major trauma and surgical procedures, including those necessitating cardiopulmonary bypass (CPB). In this population the incidence of SIRS is high, afflicting up to 70% of patients. This may be manifest from an increased vasopressor requirement, to refractory hypotension, and multiple organ dysfunction syndrome (MODS) with liver, renal, myocardial, and neurological problems. MODS is associated with significant mortality rates of around 30-45%. Survivors require prolonged and costly intensive care, thereby representing a considerable burden for the healthcare services. Survivors often suffer considerable morbidity and have significantly impaired health related quality of life.

Despite intense investigations of anti-inflammatory therapies in SIRS and its sequelae, the case of patients is largely supportive whilst underlying triggers (such as infection) for the process are treated. Indeed, the only therapy drotrecogin alfa (activated) demonstrated to reduced mortality in a randomised study has only been investigated in patients with the most severe SIRS consequent of infection (i.e. severe sepsis) and is contra-indicated in those who have just undergone surgery.

Haemolysis is a common feature of surgery requiring CPB and may potentiate the development of SIRS and organ injury through the release of heme/iron. Furthermore, haemolysis during CPB may lead to the depletion of important mechanisms which scavenge free heme/hemoglobin from the circulation. Albumin, the most abundant plasma protein, has specific and non-specific heme and iron binding sites which are used under circumstances in which standard scavengers are overwhelmed. However, albumin is also depleted following CPB. It is therefore hypothesised that by priming the CPB circuit with albumin the heme/iron scavenging capability of the plasma will be maintained following surgery and that the systemic inflammatory response will be attenuated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
16 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients over sixteen years of age undergoing surgery that requires cardiopulmonary bypass who provide informed written consent

排除标准

  • Lack of informed consent
  • Pregnancy
  • Cyanotic congenital heart disease (due to high haemoglobin levels and increased haemolysis)
  • Patients undergoing other extracorporeal interventions (ventricular assist devices, extracorporeal membrane oxygenators, pre-admission dialysis)
  • Patients with congenital haemoglobinopathies (e.g. thalassaemia, cryoglobinuria, etc)
  • Patients with disorders of iron metabolism (e.g. haemochromatosis)
  • Religious objections to transfusion of a plasma-derived product
  • Patients with known blood borne infection
  • Patients with known hypersensitivity to gelofusine or human albumin solution
  • Patients with an additive EUROSCORE of 10 or more

研究组 & 干预措施

1 Albumin

Experimental

Priming of the cardiopulmonary bypass circuit with 20% human albumin solution prior to surgery

干预措施: 20% Human albumin solution (Drug)

2 Gelofusin

Placebo Comparator

Priming of the cardiopulmonary bypass circuit with gelofusin prior to surgery

干预措施: Gelofusin (Drug)

结局指标

主要结局

Time from surgery to intensive care unit discharge

时间窗: Hourly

次要结局

  • Degree of hemolysis - free hemoglobin and haptoglobin(Prior to and at 0, 2, 6 and 24 hours after CPB)
  • Haematological and physiological markers of the inflammatory response - Temperature, pulse rate, respiratory rate, white cell count and C-reactive protein(At regular intervals following CPB until intensive care unit discharge)
  • Biochemical and physiological markers of organ dysfunction(At regular intervals following CPB until intensive care unit discharge)
  • Haematological markers of the inflammatory response(Prior to and at 0, 2, 6 and 24 hours after CPB)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验